Journals / Türkiye Acil Tıp Dergisi / 2011 / Cilt: 11 - Sayı: 2

Metoklopramide bağlı methemoglobinemi insidansı

Incidence of metoclopramide-induced methemoglobinemia

Pages
49–53
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There has been no significant difference found between methemoglobin levels and patients’ diagnoses, sex, age, comorbid diseases, and medications taken for comorbid factors.ConclusionsAlthough rarely seen, possibility of development of metoclopramide-induced methemoglobinemia following metoclopramide administration should be kept in mind.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:ObjectivesMethemoglobinemia could be a congenital or acquired condition.
📊
Key Findings & Data:We aimed to investigate the incidence of metoclopramide-induced methemoglobinemia in our emergency department (ED).MethodsAdult patients who were admitted to the ED with renal colic, peripheral vertigo, acute gastroentiritis and vascular headache and who were given a single dose of 10 mg metoclopramide for nausea and/or vomiting were involved in the study.
💡
Conclusion & Impact:There has been no significant difference found between methemoglobin levels and patients’ diagnoses, sex, age, comorbid diseases, and medications taken for comorbid factors.ConclusionsAlthough rarely seen, possibility of development of metoclopramide-induced methemoglobinemia following metoclopramide administration should be kept in mind.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

ObjectivesMethemoglobinemia could be a congenital or acquired condition. It causes clinical conditions ranging from simple cyanosis to hypoxia, lactic acidosis and death. Several cases of metoclopramide-induced methemoglobinemia both in infants and adults have been reported in literature. We aimed to investigate the incidence of metoclopramide-induced methemoglobinemia in our emergency department (ED).MethodsAdult patients who were admitted to the ED with renal colic, peripheral vertigo, acute gastroentiritis and vascular headache and who were given a single dose of 10 mg metoclopramide for nausea and/or vomiting were involved in the study. The total number of study sample was 270.ResultsOf the 270 patients, 208 (77%) were female and 62 (33%) were male. Patients’ methemoglobin levels ranged between 0.5-5.20 gr/dl with an average value of 0.97 gr/dl. There has been no significant difference found between methemoglobin levels and patients’ diagnoses, sex, age, comorbid diseases, and medications taken for comorbid factors.ConclusionsAlthough rarely seen, possibility of development of metoclopramide-induced methemoglobinemia following metoclopramide administration should be kept in mind.

Özet

AmaçMethemoglobinemi konjenital veya edinsel olarak görülür. Basit siyanozdan, hipoksi, laktik asidoz, koma ve ölüm gibi klinik tablolara neden olabilir. Literatürde gerek infant gerekse erişkinlerde metoklopramide bağlı birkaç methemoglobinemi olgusu bildirilmiştir Bu yüzden sıklıkla kullandığımız bir ilaç olan metoklopramide bağlı methemoglobinemi insidansını araştırmayı amaçladık.Gereç ve YöntemAnkara Eğitim ve Araştırma Hastanesi Acil Servisi’ne başvuran 270 hasta çalışmaya dâhil edildi. Renal kolik, periferik vertigo, akut gastroenterit (AGE) ve vasküler tip baş ağrısı tanısı alıp bulantı ve/veya kusması için tek doz 10 mg metoklopramid yapılan erişkin hastalar çalışmaya alındı.BulgularHastaların %77’si kadın %33’ü erkekti. Hastaların ortalama hemoglobin düzeyleri 10.3-15.6 gr/dl arasında iken methemoglobin düzeyleri ise 0.5-5.20 gr/dl arasında olup ortalama değer 0.97 gr/dl olarak çıktı. Hastaların acil serviste aldığı tanılara, cinsiyete, yaş gruplarına, komorbid hastalıklara ve komorbid hastalık nedeniyle ilaç kullanımına göre methemoglobinemi düzeyleri açısından herhangi bir farklılık bulunamadı.SonuçMetoclopramide uygulanması sonrasında nadir de olsa erken dönemde methemoglobinemi gelişebileceği unutulmamalıdır.

🔖

Cite This Article

COŞKUN, F., YÜZBAŞIOĞLU, Y., ASLAY, S., AKINCI, E. (2022). Metoklopramide bağlı methemoglobinemi insidansı. Türkiye Acil Tıp Dergisi, Cilt: 11 - Sayı: 2, 49–53. https://ajindex.com/articles/625998

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Michelle, Kumar M. Methemoglobinemia over view e Medicine from Web med. Available from: http://www.emedicine.medscape.com/article/956528-overview. [cited in 2010]
  2. Osterhoudt KC. Methemoglobinemia. In: Ford M, Delaney K, Ling L, Ford ET, editors. Clinical toxicology. 1st ed., Philadelphia: W. B. Saunders Company; 2001. p. 211-7
  3. Tobias JD, Ramachandran V. Intraoperative diagnosis of unsuspected methemoglobinemia due to low pulse oximetry values. J Int Care Med 2009;24:273
  4. Dutta R, Dube SK, Mishra LD, Singh AP. Acute methemglobinemia. Internet J Emerg Intensive Care Med 2008;11:1092-4051
  5. Jaffe ER. Methemoglobinemia in the differential diagnosis of cyanosis. Hosp Pract 1985;15:92-110
  6. Coleman MD, Coleman NA. Drug-induced methaemoglobinemia. Drug Safety 1996;14:394-405
  7. Saxena H, Prakash Saxena A. Acute methaemoglobinaemia due to ingestion of nitrobenzene (paint solvent). Indian J Anaesth. 2010;54:160-2
  8. Nascimento TS, Pereira RO, de Mello HL, Costa J Methemoglobinemia: from diagnosis to treatment. Rev Bras Anestesiol 2008;58:651-64
  9. Friedman BW, Corbo J, Lipton RB, et al. A trial of metoclopramide vs sumatriptan for the emergency department treatment of migraines. Neurology 2005;64:463-8
  10. Jellish WS, Kartha V, Fluder E, Slogoff S. Effect of metoclopramide on gastric fluid volumes in diabetic patients who have fasted before elective surgery. Anesthesiology 2005;102:904-9
  11. Hultquist DE. Cytochrome b5 reductase deficiency and enzymatic hereditary methemoglobinemia. In: Scriver CR, Beaudet Al, Sly Ws, Valle D, editors. The metabolic and molecular basis of inherited disease. New York: McGraw-Hill; 1995
  12. Griffin JP. Methaemoglobinaemia. Adv Drug React Toxicol Rev 1997;16:45-63
  13. Descamps IM, Gressier B, Glowacki M, et al. Neonatal methaemoglobinemia and metoclopramide: case report. Therapie 2009; 64:67-9
  14. Mérieau E, Suc AL, Beau-Salinas F, Norbert K, Saliba E, Cantagrel S. Metoclopramide and neonatal methaemoglobinemia Arch Pediatr 2005;12:438-41
  15. Gregory L. Kearns, Debra H. Metoclopramide-induced methemoglobinemia. Pediatrics 1988;82:364-6
  16. Karadsheh NS, Shaker Q, Ratroat B. Metoclopramide-induced methemoglobinemia in a patient with co-existing deficiency of glucose-6-phosphate dehydrogenase and NADH-cytochrome b5 reductase: failure of methylene bluetreatment Haematologica 2001;86:659-60
  17. Grant SC, Close JR, Bray CL. Methaemoglobinaemia produced by metoclopramide in an adult. Eur J Clin Pharmacol 1994;47